Ares Capital Set to Report Q3 Earnings: What's in Store for ARCC?

24.10.25 14:02 Uhr

Werte in diesem Artikel

Ares Capital Corporation ARCC is slated to report third-quarter 2025 results on Oct. 28, before the opening bell. Its revenues and earnings are expected to have declined on a year-over-year basis.In the last reported quarter, ARCC’s earnings missed the Zacks Consensus Estimate. Results were primarily affected by a decline in total investment income and higher expenses. However, the company’s robust portfolio activities offered some support.Ares Capital has a weak earnings surprise history. The company’s earnings lagged the Zacks Consensus Estimate in each of the trailing four quarters.Ares Capital Corporation Price and EPS Surprise Ares Capital Corporation price-eps-surprise | Ares Capital Corporation QuoteARCC’s Earnings & Sales Projections for Q3The Zacks Consensus Estimate for ARCC’s earnings is pegged at 50 cents, stable over the past seven days. The figure indicates a 13.8% decrease from the prior-year quarter.The consensus estimate for sales is pegged at $763.74 million, which suggests a 1.5% fall.Other Key Estimates for ARCC’s Q3 EarningsThe Zacks Consensus Estimate for interest income from investments (constituting a significant portion of the company’s total investment income) is pegged at $545.92 million, indicating a 3.9% dip from the prior-year quarter. The consensus mark for other income is pegged at $17.43 million, indicating a 3.2% fall. The consensus estimate for capital structuring service fees is pegged at $41.1 million, implying 8.2% growth. The Zacks Consensus Estimate for dividend income of $153.44 million suggests a 1.6% rise. Ares Capital has been witnessing higher expenses over the past several quarters. As the company has been investing in venture growth stage companies, operating costs are expected to have been elevated in the third quarter.Earnings Whispers for ARCCOur quantitative model does not conclusively predict an earnings beat for Ares Capital this time. This is because it does not have the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better.You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.Earnings ESP: Ares Capital has an Earnings ESP of 0.00%.Zacks Rank: The company currently carries a Zacks Rank #4 (Sell).Finance Sector Stocks Worth a LookHere are a couple of finance sector stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time:The Earnings ESP for Invesco IVZ is +2.81% and it carries a Zacks Rank #2 (Buy) at present. The company is scheduled to report its third-quarter 2025 results on Oct. 28.Over the past 30 days, the Zacks Consensus Estimate for IVZ’s quarterly earnings has been revised 2.3% upward to 45 cents.UMB Financial UMBF is also scheduled to release third-quarter 2025 earnings on Oct. 28. The company, which carries a Zacks Rank #3, at present, has an Earnings ESP of +0.49%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.UMBF’s quarterly earnings estimates have been revised 1.6% north to $2.48 over the past month.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Invesco Ltd. (IVZ): Free Stock Analysis Report Ares Capital Corporation (ARCC): Free Stock Analysis Report UMB Financial Corporation (UMBF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ares Capital und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Ares Capital

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ares Capital CorpShs

Wer­bung

Analysen zu Ares Capital CorpShs

DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
28.06.2016Ares Capital NeutralNational Securities
25.02.2016Ares Capital OverweightBarclays Capital
DatumRatingAnalyst
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
25.02.2016Ares Capital OverweightBarclays Capital
30.09.2015Ares Capital BuyD.A. Davidson & Co.
13.02.2015Ares Capital Market PerformBMO Capital Markets
DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
28.06.2016Ares Capital NeutralNational Securities
05.05.2015Ares Capital HoldBB&T Capital Markets
20.08.2009Allied Capital market performKeefe, Bruyette & Woods, Inc.
06.02.2007Update Allied Capital Corp.: HoldAG Edwards
DatumRatingAnalyst
06.12.2005Update Allied Capital Corp.: UnderperformHarris Nesbitt

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen